Table 4.
Assessment administration time points, target respondents, and frequency. Measurement tools including the type of data, key respondents, frequency, and time points of administration
| Survey topic | Method | Respondent(s) | Frequency | Time point(s) |
|---|---|---|---|---|
| Hospital assessment questionnaire | QUAN | LMIC site physician champion | 1 time | Prior to BHAP enrollment |
| Complexity assessment | QUAN |
Implementation team |
4 times | Pre-training, 3 and 6 months, and 1-year post-training |
| Implementation Climate Scale (ICS) | QUAN | |||
| Organization Readiness for Implementing Change (ORIC) | QUAN | |||
| Acceptability of intervention (AIM) | QUAN | |||
| Intervention Appropriateness Measures (IAM) | QUAN | |||
| Feasibility of Intervention (FIM) | QUAN | |||
| Knowledge assessment: nurses | QUAN | All nurses | 4 times | Pre-training, 3 and 6 months, and 1 year post-training |
| Knowledge assessment: pharmacy | QUAN | All pharmacists | ||
| Knowledge assessment: physician | QUAN | All physicians | ||
| Training material feedback survey | QUAL |
Implementation team |
1 time | 3 months post-training (after the 1st patient received blinatumomab) |
|
Semi-structured group interviews: 1) Training program feedback and site-specific barriers 2) Site-specific fidelity vs adaptation |
QUAL |
Implementation team |
2 times | 3 months post-training (after the 1st patient received blinatumomab) and 12 months post-training |
| Implementation strategy feedback | QUAN | Key stakeholders (implementation team, industry, St. Jude) | 1 time | Annual review |
| Program evaluation group interview | QUAL | |||
| 1 time | Annual review |
LMICs Low- and middle-income countries, BHAP Blincyto® Humanitarian Access Program, QUAN Quantitative, QUAL Qualitative